Cargando…
Choroidal thickness changes in non-treated acute and ranibizumab-treated chronic central serous chorioretinopathy
To evaluate the changes in subfoveal retinal, and choroidal thicknesses (CT) in the non-treated acute and the ranibizumab-treated chronic central serous chorioretinopathy (CSCR) patients. This retrospective study included 32 eyes of 32 consecutive patients with CSCR. There were 12 patients who prese...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221658/ https://www.ncbi.nlm.nih.gov/pubmed/30412084 http://dx.doi.org/10.1097/MD.0000000000012885 |